Search research articles
Contact Us
Filters
Showing results (271-280 of 329) with videos related to
Page
of 33
Sort By:
The Journal of Antimicrobial Chemotherapy
|
August 14, 2012
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
Almoustapha Issiaka Maiga, Djeneba Bocar Fofana, Mamadou Cisse, et al.
AIDS (London, England)
|
July 23, 2020
No HIV-1 molecular evolution on long-term antiretroviral therapy initiated during primary HIV-1 infection
Basma Abdi, Thuy Nguyen, Sophie Brouillet, et al.
Ticks and Tick-Borne Diseases
|
November 15, 2023
Seroprevalence of Crimean-Congo hemorrhagic fever virus among people living with HIV in Brazzaville, Congo and among blood donors in Bamako, Mali
Gervillien Arnold Malonga, Almoustapha Issiaka Maiga, Dimitry Moudiongui Mboungou Malanda, et al.
The Journal of Antimicrobial Chemotherapy
|
May 4, 2019
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations
Louise Castain, Marine Perrier, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
September 22, 2011
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype
Isabelle Malet, Slim Fourati, Charlotte Charpentier, et al.
Journal of Medical Virology
|
April 30, 2026
KSHV Genome in Saliva, Whole Blood and Kaposi's Sarcoma Biopsy Specimens in Republic of Congo: Phylogenetic Analysis and an APOBEC3B Mutational Signature
Gervillien Arnold Malonga, Valentin Leducq, Antoine Fauchois, et al.
The Journal of Antimicrobial Chemotherapy
|
April 15, 2021
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients
Romain Palich, Basma Abdi, Marc Wirden, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2009
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes
Almoustapha Issiaka Maïga, Diane Descamps, Laurence Morand-Joubert, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2012
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice
Sidonie Lambert-Niclot, Bernard Masquelier, Isabelle Cohen Codar, et al.
Research Square
|
October 14, 2024
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among Children attending the Pediatric Hospital in Bamako, Mali (BamaCoV-Kids Study)
Almoustapha Issiaka Maiga, Amadou Kodio, Salimata Alou Ouedrago, et al.
Page
of 33
Search research articles
Search
Showing results (271-280 of 329) with videos related to
Sort By:
Page
of 33
The Journal of Antimicrobial Chemotherapy
|
August 14, 2012
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting
Almoustapha Issiaka Maiga, Djeneba Bocar Fofana, Mamadou Cisse, et al.
AIDS (London, England)
|
July 23, 2020
No HIV-1 molecular evolution on long-term antiretroviral therapy initiated during primary HIV-1 infection
Basma Abdi, Thuy Nguyen, Sophie Brouillet, et al.
Ticks and Tick-Borne Diseases
|
November 15, 2023
Seroprevalence of Crimean-Congo hemorrhagic fever virus among people living with HIV in Brazzaville, Congo and among blood donors in Bamako, Mali
Gervillien Arnold Malonga, Almoustapha Issiaka Maiga, Dimitry Moudiongui Mboungou Malanda, et al.
The Journal of Antimicrobial Chemotherapy
|
May 4, 2019
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations
Louise Castain, Marine Perrier, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
September 22, 2011
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype
Isabelle Malet, Slim Fourati, Charlotte Charpentier, et al.
Journal of Medical Virology
|
April 30, 2026
KSHV Genome in Saliva, Whole Blood and Kaposi's Sarcoma Biopsy Specimens in Republic of Congo: Phylogenetic Analysis and an APOBEC3B Mutational Signature
Gervillien Arnold Malonga, Valentin Leducq, Antoine Fauchois, et al.
The Journal of Antimicrobial Chemotherapy
|
April 15, 2021
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients
Romain Palich, Basma Abdi, Marc Wirden, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2009
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes
Almoustapha Issiaka Maïga, Diane Descamps, Laurence Morand-Joubert, et al.
The Journal of Antimicrobial Chemotherapy
|
June 27, 2012
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice
Sidonie Lambert-Niclot, Bernard Masquelier, Isabelle Cohen Codar, et al.
Research Square
|
October 14, 2024
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among Children attending the Pediatric Hospital in Bamako, Mali (BamaCoV-Kids Study)
Almoustapha Issiaka Maiga, Amadou Kodio, Salimata Alou Ouedrago, et al.
Page
of 33